Modulation Of Tumor Immunity

Patent No. EP3036256 (titled "Modulation Of Tumor Immunity") was filed by Merck Sharp & Dohme on Aug 18, 2014. The application was issued on Oct 28, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PAJAROJul 28, 2021ALT, MICHAEL HELMUT
REGENERON PHARMACEUTICALSJul 27, 2021HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3036256

MERCK SHARP & DOHME
Application Number
EP14761460A
Filing Date
Aug 18, 2014
Status
Revoked
Oct 27, 2023
Publication Date
Oct 28, 2020